GlassScriptPhysician profile
Timothy C Brand
NPI 1164539136
$5,558.91
in general payments reported to CMS, 2019-2025
32 companies · $928 in 2025
The $928 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2022: $1,380 · 2023: $483 · 2024: $2,557 · 2025: $928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,280 · Travel and Lodging: $1,669 · Education: $19.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,280.39 |
| Travel and Lodging | $1,669.10 |
| Education | $19.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,704.60 | 2022-2025 | Urolift |
| Janssen Scientific Affairs, LLC | $757.50 | 2022 | |
| Janssen Biotech, INC. | $249.42 | 2022-2025 | Erleada, Akeega |
| Coloplast Corp | $203.68 | 2022-2024 | Speedicath |
| Medtronic USA, INC. | $175.61 | 2019 | |
| Sumitomo Pharma America, INC. | $170.02 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $131.94 | 2022-2025 | Botox |
| Medtronic, INC. | $107.60 | 2022-2025 | Avalus, Mosaic, Penditure |
| Boston Scientific Corporation | $103.31 | 2023-2025 | Spaceoar Vue System - 10ml, Advantage System, Lithovue |
| Pfizer INC. | $100.99 | 2023-2025 | |
| Urogen Pharma, INC. | $89.38 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $88.07 | 2022-2023 | Aveed, Xiaflex, Edex |
| Intuitive Surgical, INC. | $87.50 | 2025 | |
| Novartis Pharmaceuticals Corporation | $67.01 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $64.61 | 2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $64.31 | 2022-2025 | |
| Urovant Sciences INC | $59.78 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $56.89 | 2022 | |
| Telix Pharmaceuticals | $40.53 | 2024-2025 | Illuccix |
| Karl Storz Endoscopy-America | $34.61 | 2019 | |
| Procept Biorobotics Corporation | $33.69 | 2025 | |
| Astellas Pharma US INC | $32.02 | 2022-2024 | Xtandi |
| Civco Medical Instruments | $22.27 | 2025 | |
| Ambu INC. | $22.22 | 2025 | |
| Abc Home Medical Supply, INC. | $18.52 | 2022 | |
| Hollister Incorporated | $16.00 | 2023 | Infyna Chic, Onli, Vapro Pocket |
| Tolmar, INC. | $15.96 | 2023 | |
| Ferring Pharmaceuticals INC. | $15.25 | 2025 | Adstiladrin |
| Olympus America INC. | $15.08 | 2024 | Itind System |
| Laborie Medical Technologies Corp. | $10.54 | 2025 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Brand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.